Point/counterpoint: Randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma

Stuart A. Grossman, Karisa C. Schreck, Karla Ballman, Brian Alexander

Research output: Contribution to journal › Review article › peer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Point/counterpoint: Randomized versus single-arm phase II clinical trials for patients with newly diagnosed glioblastoma'. Together they form a unique fingerprint.